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Abstract
Background: To be effective, national malaria guidelines must be properly followed. This study evaluated nurses’
practices in the management of uncomplicated malaria cases at a District Hospital. Its objective was to identify the
reasons for discrepancies between official guidelines and usual practices.
Methods: This study took place at Oussouye hospital, south-western Senegal. Blood smears were available for
biological diagnosis in patients aged more than five years while the Integrated Management of Childhood Illness
recommended treating fevers presumptively in children under five. First line anti-malarial was Amodiaquine plus
sulphadoxine-pyrimethamine (AQ+SP) bi-therapy. Hospital records of children under 13 years of age seen between
2004 and 2005 were reviewed.
Results: Among children treated with anti-malarials, 74% (2, 063/2, 789) received AQ+SP. However, only 22% (406/
1, 879) of febrile children and 19% (429/2, 198) of children diagnosed with malaria got a blood smear. Moreover,
an anti-malarial was prescribed for 80% (377/474) of children with a negative blood smear.
Conclusions: The transition from chloroquine to AQ+SP was well followed. Nonetheless, blood smear use was very
low and many over-prescriptions were reported. Reasons for discrepancies between guidelines and practices can
be classified in three main categories: ambiguous guidelines, health system’s dysfunctions and nurses’ own
considerations. Aside from the strengthening of the public health system, in order to guarantee practices
complying with guidelines, training content should be more adapted to nurses’ own considerations.
Background
In the past, while first and second line recommended
anti-malarials were chloroquine (CQ), sulphadoxine-pyr-
imethamine (SP) or amodiaquine (AQ) mono-therapy,
blood smears were found to be infrequently used despite
being available, and non-recommended prescriptions
were frequent. In Zambia in 1997, a blood smear was
requested for only 46% of patients with fever or previous
fever, and among those with a negative result, 35% were
treated with an anti-malarial [1]. In Kenya in 2002 [2]
and in Tanzania in 2004 [3], this percentage was 79%
and 48% respectively. Moreover, Barat et al [1] and Zur-
ovac et al [2] reported 11% and 43% respectively of
patients without any history of fever treated with an
anti-malarial. As far as the choice of prescribed anti-
malarial is concerned, three studies showed prescrip-
tions not complying with guidelines. In Benin in 1999
[4], in Tanzania in 2003 [5] and in Kenya in 2001 [6],
quinine (QN), although restricted to severe malaria, was
prescribed for 33%, 19% and 12% respectively of chil-
dren under five treated with an anti-malarial. Moreover,
in Kenya, 15% of children received a combination of
CQ, AQ or SP.
Only a few studies, however, researched the reasons
for these non-recommended practices [1,7,8]. This
study, therefore, evaluated nurses’ practices in the
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trict Hospital in Senegal. Its objective was to identify the
reasons for discrepancies between official guidelines and
usual practices.
Methods
Study site
This study took place from July to September 2005 at
the District Hospital of Oussouye, south-western Sene-
gal. In this area, malaria is meso-endemic with a seaso-
nal recrudescence of cases during the rainy season, from
June to October. The hospital was managed by a physi-
cian and was the referral centre for twelve dispensaries
within the district. Two out-patient consultation rooms
managed by nurses were available, one for children and
one for adults. Consultations with a physician were also
offered in a third room. The hospital had a laboratory
facility managed by a skilled technician and equipped
for blood smears. These services were open from Mon-
day to Friday, 8:30 to 13:00.
At the time of this study and since 2003, national
malaria guidelines recommended AQ+SP bi-therapy for
treating uncomplicated malaria [9]. In addition, in chil-
dren under five, the Integrated Management of Child-
hood Illness (IMCI) advocated presumptive treatments
of fevers or previous fevers [10]. In patients over five,
healthcare providers should make a differential diagnosis
of fevers. Where blood smears were available, this biolo-
gical diagnostic tool had to be used.
Collection and analysis of data from Hospital records
A total of 5, 441 consultations involving children
younger than 13 years old diagnosed with malaria or
treated with an anti-malarial were retrospectively
extracted from 2004 and 2005 hospital records. For each
of these consultations, following data were recorded:
out-patient consultation room, date, age, sex, axillary
temperature, blood smear result if requested, diagnosis
and prescribed anti-malarial. History of previous fever
was not consigned in consultation records.
Nine point five percent (517/5, 441) of extracted con-
sultations were excluded from the analysis: 235 consul-
tations involving infants less than two months old, the
IMCI recommending to treat fevers with antibiotics in
this age group, and 282 consultations with missing data
(age, diagnosis or treatment). A total of 4, 924 consulta-
tions were, therefore, analysed: 2, 371 in 2004 and 2,
553 in 2005.
Blood smear use was determined according to the pre-
sence of fever (axillary temperature ≥ 37.5°C) and diag-
nosis made by nurses, malaria or other illness. Two
aspects of anti-malarial prescription practices were ana-
lysed: The type of anti-malarials prescribed and the type
of patients treated, febrile or not, with a positive or
negative blood smear, and diagnosed with malaria or
another illness. These analyses were performed in two
age groups: under-five and from five to 13 years old.
Statistical analyses were performed using STATA10.
Pearson’s chi square tests were used to compare two
percentages (a = 0.05).
Results
Figure 1 shows children’s healthcare according to the
chronological order of events during consultations: tem-
perature measurement, blood smear request, determined
diagnosis and anti-malarial prescription. 57% (2, 814/4,
924) of children were under five. Eighty two percent (4,
041/4, 924) of children were seen in the paediatric con-
sultation room, 17% (853/4, 924) in the adult consulta-
tion room and 1% (30/4, 924) in the physician’s room.
Nurses measured the temperature of 71% (3, 506/4, 924)
of children. Overall 54% (1, 879/3, 506) were febrile,
57% (1, 144/2, 009) of children under five and 49%
(735/1, 497) of children from five to 13 years old (p <
0.0001).
Blood smears use
Only 22% (406/1, 879) of febrile children were referred
to the laboratory facility for a blood smear. Their mean
axillary temperature was 38.3 ± 0.7°C (n = 404) versus
38.2 ± 0.8°C (n = 1, 473) in febrile but non-referred
children. Moreover, only 19% (429/2, 198) of children
diagnosed with malaria got a blood smear. Among
them, only 30% (127/429) had a positive result.
By age, the use of blood smears was similar. Twenty
three percent (262/1, 144) of febrile children under five
and 20% (144/735) of febrile children from five to 13
years old were referred for a blood smear (p = 0.09).
And, when they were diagnosed with malaria, 22% (224/
1, 038) and 18% (205/1, 160) respectively were referred
for a blood smear (p = 0.02).
Nurses also requested a blood smear in 11% (186/1,
627) of non-febrile children and 6% (172/2, 726) of chil-
dren diagnosed with a non-malarial illness.
Type of anti-malarials prescribed
The transition to AQ+SP was well followed, 74% (2,
063/2, 789) of children treated with an anti-malarial
received this bi-therapy (Figure 2). From 2004 to 2005,
its use increased from 64% (926/1, 438) to 84% (1, 137/
1, 351) (p < 0.0001). Mono-therapy prescriptions were
minor, 5.0% (149/2789) for AQ, 1.1% (30/2789) for
Artesunate (AS) and 0.8% (22/2789) for CQ. Other anti-
malarial treatments were very rarely prescribed, 1.7%
(48/2789) for AS+AQ and 0.4% (12/2789) for AS+SP.
Regarding the use of QN, 3% (81/2789) of treated chil-
dren received IV injection and 14% (379/2789) IM
injection.
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According to the presence or not of fever, nurses pre-
scribed an anti-malarial to 86% (1, 616/1, 879) of febrile
children and 65% (1, 055/1, 627) of non-febrile children
(table 1). Among non-febrile children who received an
anti-malarial, 73% (775/1, 055) were diagnosed with
malaria. According to the results of blood smear, 100%
(127/127) of children with a positive result and 80%
(377/474) of children with a negative result were treated
with an anti-malarial. Among those with a negative
4924 children from 2 months to 13 years old
71% (3506) known T° 29% (1418) unknown T°
22% (406) R 78% (1473) NR
54% (1879) T° ≥ 37,5 °C 46% (1627) T°  37,5 °C
20% (81) BS+ 5 BS+ 4 BS-
100% 'M
67% (216) 'M
34% (109) 'O
100% T  100% (216) T
54% (59) T
80% (325) BS-
70% (1028) 'M
30% (445) 'O
100% (1028) T
52% (232) T
11% (186) R
22% (41) BS+ 78% (145) BS-
100% 'M
57% (83) 'M
43% (62) 'O
89% (1441) NR
45% (651) 'M
55% (790) 'O
100% (83) T
26% (16) T
100% T  100% (651) T
33% (264) T
1% (9) R 99% (1409) NR
100% 'M
3 'M
1 'O
100% T.  3 T
0 T
6% (90) 'M
94% (1319) 'O
100% (90) T
2% (20) T
T°: Axillary Temperature
R: Referred to the laboratory facility
NR: Non-Referred to the laboratory facility
BS: Blood Smear
'M: Malaria diagnosis
'O: Other diagnosis
T : Treated with an antimalarial
Figure 1 Children’s healthcare according to the chronological order of events during consultations. T°: Axillary temperature. R: Referred
to the laboratory facility. NR: Non-referred to the laboratory facility. BS: Blood smear. ΔM: Malaria diagnosis. ΔO: Other diagnosis. T: Treated with
an anti-malarial.
Figure 2 Type of anti-malarials prescribed. Red quarter represents the proportion of children treated with AQ+SP. Dark green quarter
represents the proportion of children treated with IM QN. Pale green quarter represents the proportion of children treated with AQ. Blue quarter
represents the proportion of children treated with IV QN. Purple quarter represents the proportion of children treated with other anti-malarials.
Other include AS+AQ: 1.7% (48/2789); AS: 1.1% (30/2789); CQ: 0.8% (22/2789); AS+SP: 0.4% (12/2789).
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377) were diagnosed with malaria.
Lastly, given the diagnosis recorded by nurses, 100%
(2, 198/2, 198) of children diagnosed suffering from
malaria and 22% (591/2, 726) of children diagnosed suf-
fering from a non-malarial illness received an anti-
malarial. Among those treated while diagnosed with a
non-malaria illness, 51% (291/571) were febrile. The
main diagnosis recorded were respiratory infections, for
76% (452/591), or gastro-intestinal infections, for 21%
(123/591).
In children under five and in those from five to 13
years old respectively, the percentages of treated chil-
dren were 60% (516/865) and 71% (539/762) in the
absence of fever (p < 0.0001); 77% (235/305) and 84%
(142/169) when blood smears were negative (p = 0.07);
27% (472/1, 776) and 13% (119/950) when a non-malar-
ial illness was diagnosed (p < 0.0001). Overall, 54% (1,
510/2, 814) of children under five and 61% (1, 279/2,
110) of those aged from five to 13 received an anti-
malarial (p < 0.0001).
Discussion
In Senegal, artemisinin-based combination therapy
(ACT) and rapid diagnostic tests (RDT) have been
implemented in 2006 after a transitory stage recom-
mended AQ+SP bi-therapy [11]. This study took place
at a District Hospital duringt h i st r a n s i t o r ys t a g ea n d
allowed evaluation of the context of uncomplicated
malaria cases management into which ACT and RDT
were later introduced. It identified discrepancies
between official guidelines and nurses’ usual practices
and tried to explain their determinants.
Compliance with the transition to AQ+SP bi-therapy
The transition to AQ+SP was well followed at Oussouye
Hospital. This result can be attributed to the favourable
context of prescription in place in a District Hospital.
Indeed, nurses were trained and regularly supervised by
the hospital physician. Moreover, stocks of CQ were
removed and those of AQ+SP never experienced shortage.
These good practices contrast with those reported in
2004, in Thies, north-western Senegal, where nurses
prescribed AQ or SP mono-therapy for 15% to 78% of
presumptive malaria cases [12]. Similarly, in Zambia in
2004 and in Kenya in 2006, only 13% and 34% of treated
children received artemether/lumefantrine (A/L), the
first line anti-malarial [13,14]. Even if these three studies
reported prescription practices while the new therapy
has been recommended for a few months, in Zambia,
two years later, only 47% of treated children received A/
L [15]. In contrast to this study, health facilities studied
were dispensaries. To explain their results, authors
reported health system’s dysfunctions such as the avail-
ability of previous recommended anti-malarials,
shortages of new anti-malarials and a lack of medical
staff’s training and supervision. While “cascade” training
had been planned at the time of new guidelines deploy-
ment, in Senegal [12] and Kenya [8], it was delayed at
the lowest level of the health pyramid by reason of lack
of Global Fund subventions. The facility’sl o c a t i o no n
the health pyramid seems therefore to be a major com-
ponent. The higher the facility is located up the pyra-
mid, the more it benefits from a favourable context for
good healthcare practices.
In addition, to justify non-recommended prescriptions,
nurses from Thies [12] and Kenya [8] explained they
deviated from guidelines in response to certain practical
or clinical situations. These situations encompassed the
risk of an excessive dose in case of repeated prescrip-
tions of SP, the paediatric forms’ convenience, patients’
demands or adjusted prescriptions in case of high fevers
or adverse events of AQ.
In Oussouye, informal interviews with nurses showed
similar concerns and the extent to which guidelines
describe standard clinical cases while nurses are con-
fronted with various individual situations, which can
lead to non-recommended prescriptions. In the paedia-
tric consultation room, nurses preferred to prescribe
AQ alone when SP had been taken in the previous
month to adhere to the one-month minimum interval
recommended by the Intermittent Preventive Therapy
during pregnancy. When patients had started to self-
medicate with CQ, AQ or AS, nurses could carry on
with this treatment, conscious of some households’ low
incomes. In young children, they could choose to pre-
scribe AS suppositories because of their convenience. In
the adult consultation room, in cases of high fever, one
particular nurse preferred to prescribe AS because of its
effectiveness. Lastly, all nurses explained that pressure
from parents can sometimes affect their prescribing.
Parents wanted IM QN because it was perceived as
being more effective or AQ drinkable suspension to
store at home for treating fevers. Others refused AQ
Table 1 Types of patients treated
No. children % treated (n)
Febrile 1 879 86.0 (1616)
Non febrile 1 627 64.8 (1055)
Missing temperature 1 418 8.3 (118)
Positive blood smears 127 100.0 (127)
Negative blood smears 474 79.5 (377)
Malaria diagnosis 2 198 100.0 (2198)
Other diagnosis 2 726 21.7 (591)
Total of consulted children 4 924 56.6 (2789)
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aches, nausea or itching.
To conclude, it seems there are two kinds of potential
impediments to the compliance with guidelines, first
linked to the running of the health facility or its level in
the health pyramid, and second linked to medical staff’s
handling of situations that they encounter daily with
their patients.
Low use of blood smears and over-prescriptions
At Oussouye Hospital, compliance with the transition to
AQ+SP has to be balanced. Indeed, while a laboratory
facility was available, a very small proportion of patients
g o tab l o o ds m e a r .I na d d i t i o n , three types of over-pre-
scription were identified. Sixty five percent (1, 055/1,
627) of non-febrile children were treated. However, as
no history of previous fever was consigned in consulta-
tion records, these over-prescriptions are probably over-
estimated. Secondly, 22% (591/2, 726) of children diag-
nosed with a non-malaria illness were treated. These
over-prescriptions explain why 57% (2, 789/4, 924) of
children received an anti-malarial, while only 45% (2,
198/4, 924) were diagnosed with malaria. Lastly, and
more surprisingly, 80% (377/474) of children received an
anti-malarial despite their negative blood smear. These
over-prescriptions explain why 84% (504/601) of chil-
dren referred to the laboratory facility for a blood smear
received an anti-malarial, while the positive blood smear
percentage was only 21% (127/601).
In a context of RDT deployment, similar results were
reported. In Zambia in 2006, about one year after their
introduction, only 23% of patients with fever or previous
fever were tested. Moreover, 36% of patients with a
negative RDT were treated with an anti-malarial [16]. In
Tanzania in 2005, this proportion rose to 54% [17].
Despite their many advantages, the use of RDT could
therefore encounter similar problems to those identified
with blood smears.
Considering observations made at Oussouye Hospital
and informal interviews with its medical staff, three
spheres of influence seem to lead to these discrepancies
in guidelines. Firstly, an ambiguous guideline enacted by
the hospital physician, recommending to treat fevers
with a negative blood smear as “ap r e c a u t i o n “ if no
other illness was diagnosed, probably affected nurses’
prescribing. This type of ambiguous guideline is offi-
cially found in other sub-Saharan countries [7,18]. In
Zambia, Hamer et al [16] also pointed out the ambiguity
of the guideline in the case of negative results. However,
from the clinicians’ point of view, it is justified by the
risk of severe malaria in cases of false negative result.
Furthermore, the multiplicity of guidelines, with IMCI,
could also contribute to over-prescriptions. Indeed, this
strategy recommends presumptive treatments of fevers
in children under five to reduce malaria mortality.
Nurses could, therefore, have applied this principle to
older children, considering that there is no age limit for
the risk of severe malaria.
Alongside guidelines, dysfunctions at the laboratory
facility also resulted in practices not complying with
guidelines. Both nurses and laboratory technician
pointed out the high workload required by blood
smears, especially results reading time, and technical or
material problems such as lack of supplies, microscope
failures or power cuts. As a result, nurses confessed they
were most of the time discouraged to request blood
smears. Moreover, the laboratory technician explained
that he was sometimes able to read blood smears only
after the end of consultations leading nurses to prescribe
without knowledge of their negative results. These dys-
functions have been reported in other sub-Saharan
countries [1,7,19]. At two Tanzanian regional hospitals,
they led to both a low use of blood smears and a delay
in reading 56% of referred patients’ slides [7].
While RDT do not require either microscope or elec-
tricity and hence avoid material problems, their usage
still requires time, in particular at least 15 minutes
before the results can be read. At dispensaries where the
mean consultation time is often very short, in particular
five minutes or less during the rainy season in Kenya or
in Tanzania [2,20], it seems probable that nurses, who
have to perform these tests, take shortcuts. In Senegal,
some nurses considered the delay to obtain results as
being still too long [21].
Lastly, at Oussouye Hospital, nurses’ own considera-
tions seem to have played an important role in explain-
ing both the low blood smear use and over-
prescriptions. To explain low blood smear use, nurses
blamed a lack of healthcare’s organisation. The long per-
iod of time to obtain results led to an accumulation of
patients at the laboratory and consequently delayed the
end of consultations. Patients returning from laboratory
also disrupted the clinic as they sometimes pushed in
front of other waiting patients creating confusion and
dissatisfaction. In addition, due to restricted laboratory
opening times, nurses were not able to refer patients for
a blood smear after 1 pm. In Zambia, Barat et al [1]
also reported a very long consultation time, on average
57 ± 31 minutes, when blood smears were requested.
Moreover, authors emphasized the absence of full-time
laboratory facilities.
Another concern of Oussouye nurses was that patients
refused to have a blood smear due to its cost (300 CFA
or 0.46 Euro) and time involved. These refusals must be
interpreted thoroughly. Indeed, patients build their own
diagnosis and therapeutic approach through what they
learn from different sources of information, in particular
practices observed during consultations [22]. Therefore,
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malarials whether or not they had been referred and,
worse, whatever the result of their blood smear. These
practices probably did not convince them of the useful-
ness of this exam.
To justify over-prescriptions, nurses’ own considera-
tions encompassed their lack of trust in the reliability of
negative blood smears due to laboratory dysfunctions
and their perceptions of malaria. Indeed, beyond stan-
dard symptoms of malaria, all nurses described atypical
malaria cases, such as “non-febrile malaria“ suspected in
patients with headaches, chills, asthenia or vomiting,
and “hidden malaria“ in which the blood smear is nega-
tive because parasites are not yet in the blood. Further-
more, nurses mentioned once again some situations
encountered with their patients, such as parents’
demands for an anti-malarial or previous self-medication
with an anti-malarial or an antipyretic which can explain
the absence of fever or the negativity of blood smear
and, therefore, do not exclude an anti-malarial prescrip-
tion. In Tanzania, Chandler et al [7] interviewed nurses
who shared some of these considerations, such as the
doubt about the reliability of negative blood smears, the
notion of false negative results because of parasites
sequestration and patients demanding an anti-malarial.
Although blood smears are reliable when performed by
a skilled technician, their sensitivity in routine practice
can be mediocre [2,3,23]. Besides technical or material
problems, the lack of qualified laboratory staff is another
frequent reason for unreliable blood smear results [24].
In such a context, the lack of confidence expressed by
nurses cannot be blamed.
Although RDT are considered reliable, nurses could
also doubt their negative results. In Tanzania, within rou-
tine practice, their sensitivity was evaluated between 19%
and 86% [25]. In this country and in Sudan [26], three
types of error were frequently observed: inadequate capil-
lary blood sample volume, incorrect waiting time to read
results and low intensity positive results read as negative.
Moreover, inadequate storage conditions, such as tem-
peratures above 35°C or humidity, frequent in sub-
Saharan Africa, can also affect the quality of RDT [27].
To summarise, over-prescriptions seem to be
explained by practical, technical or socio-cultural con-
siderations more than by clinical considerations. None-
theless, as an underlying concern, interviews with
Oussouye nurses also revealed their fear of severe
malaria in non-treated patients. In Tanzania, Chandler
et al [7] revealed the same dogma: malaria is a frequent
and fatal illness that nurses have to treat as a priority.
This fear can be explained by personal experiences,
campaigns against malaria highlighting the lethality of
this disease, but also by the training of medical staff
which put a slant on the risk of severe malaria. In order
to rationalize prescriptions, it therefore seems important
to consider this fear and appease it.
Conclusion
This study showed how difficult it is to integrate guide-
lines into nurses’ daily practices. Reasons for discrepan-
cies between official guidelines and usual practices can
be classified in three main categories: the ambiguity and
multiplicity of guidelines, health system dysfunctions
and nurses’ own considerations.
One objective of the “Roll Back Malaria” partnership
for 2015 is to treat correctly 80% of patients with
malaria. To achieve this objective, the WHO has advo-
cated, since 2001, the use of ACT for treating uncompli-
cated malaria [28] and, since 2006, the biological
confirmation of malaria cases by RDT [29]. However, in
practice, impacts of these diagnostic and therapeutic
interventions depend, in part, on whether the official
guidelines are followed by medical staff. Therefore a
favourable context for their deployment must be cre-
ated. In particular, a quality control system for biological
diagnosis seems essential to gain the trust of nurses.
Moreover, aside from the strengthening of the public
health system, there is an important need to further
match both training content and tools provided to med-
ical staff, such as algorithm, to their own considerations.
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